Patents Assigned to Omnicorder Technologies, Inc.
  • Patent number: 5999843
    Abstract: The present invention comprises methods for cancer detection involving the measurement of temporal periodic changes in blood perfusion, associated with immune response, occurring in neoplastic lesions and their surrounding tissues. Particularly, the method for cancer detection involves the detection of non-neuronal thermoregulation of blood perfusion, periodic changes in the spatial homogeneity of skin temperature, aberrant oscillations of spatial homogeneity of skin temperature and aberrant thermoregulatory frequencies associated with periodic changes in the spatial homogeneity of skin temperature.
    Type: Grant
    Filed: April 20, 1998
    Date of Patent: December 7, 1999
    Assignee: OmniCorder Technologies, Inc.
    Inventor: Michael Anbar
  • Patent number: 5961466
    Abstract: A method for measuring the periodicity of changes in blood perfusion over large regions of skin so as to identify a locally impaired neuronal control, thereby providing a quick and inexpensive screening test for relatively shallow neoplastic lesions, such as breast cancer, is described. The present method is predicated on infrared imaging of the skin to detect changes in the spectral structure and spatial distribution of thermoregulatory frequencies (TRFs) over different areas of the skin.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: October 5, 1999
    Assignee: Omnicorder Technologies, Inc.
    Inventor: Michael Anbar